Geode Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.88M | Sell |
939,726
-721
| -0.1% | -$2.7K | ﹤0.01% | 2866 |
|
|
2025
Q4 | $3.76M | Buy |
940,447
+860,789
| +1,081% | +$3.13M | ﹤0.01% | 2917 |
|
|
2025
Q3 | $272K | Buy |
79,658
+30,512
| +62% | +$78.7K | ﹤0.01% | 3833 |
|
|
2025
Q2 | $93.4K | Sell |
49,146
-71,510
| -59% | -$293K | ﹤0.01% | 4074 |
|
|
2025
Q1 | $856K | Buy |
120,656
+4,082
| +4% | +$56.2K | ﹤0.01% | 3356 |
|
|
2024
Q4 | $2.57M | Buy |
116,574
+1,657
| +1% | +$26.4K | ﹤0.01% | 3045 |
|
|
2024
Q3 | $2.31M | Sell |
114,917
-2,268
| -2% | -$47.3K | ﹤0.01% | 3077 |
|
|
2024
Q2 | $2.04M | Buy |
117,185
+19,004
| +19% | +$622K | ﹤0.01% | 3123 |
|
|
2024
Q1 | $4.09M | Buy |
98,181
+4,766
| +5% | +$133K | ﹤0.01% | 2805 |
|
|
2023
Q4 | $2.35M | Buy |
93,415
+5,318
| +6% | +$129K | ﹤0.01% | 3040 |
|
|
2023
Q3 | $2.88M | Buy |
88,097
+9,757
| +12% | +$426K | ﹤0.01% | 2923 |
|
|
2023
Q2 | $4.56M | Buy |
78,340
+41,384
| +112% | +$2.13M | ﹤0.01% | 2730 |
|
|
2023
Q1 | $965K | Buy |
36,956
+17,372
| +89% | +$509K | ﹤0.01% | 3365 |
|
|
2022
Q4 | $583K | Buy |
19,584
+3,129
| +19% | +$148K | ﹤0.01% | 3593 |
|
|
2022
Q3 | $844K | Buy |
16,455
+10,137
| +160% | +$350K | ﹤0.01% | 3481 |
|
|
2022
Q2 | $182K | Buy |
6,318
+209
| +3% | +$7.95K | ﹤0.01% | 4328 |
|
|
2022
Q1 | $320K | Buy |
6,109
+174
| +3% | +$9.98K | ﹤0.01% | 4153 |
|
|
2021
Q4 | $407K | Hold |
5,935
| – | – | ﹤0.01% | 4153 |
|
|
2021
Q3 | $941K | Buy |
5,935
+538
| +10% | +$88.5K | ﹤0.01% | 3713 |
|
|
2021
Q2 | $1.05M | Sell |
5,397
-3,209
| -37% | -$807K | ﹤0.01% | 3565 |
|
|
2021
Q1 | $2.22M | Buy |
8,606
+58
| +0.7% | +$15.2K | ﹤0.01% | 3210 |
|
|
2020
Q4 | $1.65M | Buy |
8,548
+448
| +6% | +$88K | ﹤0.01% | 3181 |
|
|
2020
Q3 | $1.65M | Buy |
8,100
+501
| +7% | +$120K | ﹤0.01% | 2976 |
|
|
2020
Q2 | $2.12M | Buy |
7,599
+618
| +9% | +$169K | ﹤0.01% | 2804 |
|
|
2020
Q1 | $2.09M | Buy |
6,981
+950
| +16% | +$270K | ﹤0.01% | 2648 |
|
|
2019
Q4 | $1.94M | Buy |
6,031
+2,213
| +58% | +$794K | ﹤0.01% | 3021 |
|
|
2019
Q3 | $1.46M | Buy |
3,818
+15
| +0.4% | +$5.94K | ﹤0.01% | 3089 |
|
|
2019
Q2 | $1.71M | Buy |
3,803
+3,373
| +784% | +$1.71M | ﹤0.01% | 3043 |
|
|
2019
Q1 | $224K | Buy |
430
+63
| +17% | +$34.8K | ﹤0.01% | 3702 |
|
|
2018
Q4 | $153K | Buy |
367
+117
| +47% | +$44.6K | ﹤0.01% | 3746 |
|
|
2018
Q3 | $72K | Buy |
250
+27
| +12% | +$11.5K | ﹤0.01% | 3982 |
|
|
2018
Q2 | $145K | Buy |
223
+46
| +26% | +$151K | ﹤0.01% | 3797 |
|
|
2018
Q1 | $729K | Buy |
+177
| New | +$515K | ﹤0.01% | 3267 |
|
Other funds holding XFOR
EAM
BCLSI
PA
SVCM
DTC
KCM
VCM
B